[HTML][HTML] COVID-19 and preexisting comorbidities: risks, synergies, and clinical outcomes
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated
symptoms, named coronavirus disease 2019 (COVID-19), have rapidly spread worldwide …
symptoms, named coronavirus disease 2019 (COVID-19), have rapidly spread worldwide …
[HTML][HTML] The impact of pre-existing comorbidities and therapeutic interventions on COVID-19
LA Callender, M Curran, SM Bates… - Frontiers in …, 2020 - frontiersin.org
Evidence from the global outbreak of SARS-CoV-2 has clearly demonstrated that individuals
with pre-existing comorbidities are at a much greater risk of dying from COVID-19. This is of …
with pre-existing comorbidities are at a much greater risk of dying from COVID-19. This is of …
[HTML][HTML] COVID-19 and comorbidities: Deleterious impact on infected patients
The pandemic situation with the emergence of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) from China has endangered human lives. Coronavirus …
coronavirus 2 (SARS-CoV-2) from China has endangered human lives. Coronavirus …
Interrelations between COVID-19 and other disorders
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory tract
virus that causes Coronavirus disease (COVID-19). The virus originated in Wuhan, China, in …
virus that causes Coronavirus disease (COVID-19). The virus originated in Wuhan, China, in …
[HTML][HTML] Comorbidities' potential impacts on severe and non-severe patients with COVID-19: A systematic review and meta-analysis
S Cheng, Y Zhao, F Wang, Y Chen, AC Kaminga, H Xu - Medicine, 2021 - journals.lww.com
Background: An ongoing outbreak of pneumonia associated with the severe acute
respiratory coronavirus (SARS-CoV-2) emerged in December 2019 in Wuhan, China …
respiratory coronavirus (SARS-CoV-2) emerged in December 2019 in Wuhan, China …
[HTML][HTML] Mechanistic insights into the immune pathophysiology of COVID-19; an in-depth review
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), which causes
coronavirus-19 (COVID-19), has caused significant morbidity and mortality globally. In …
coronavirus-19 (COVID-19), has caused significant morbidity and mortality globally. In …
[HTML][HTML] Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis
Y Zhou, Q Yang, J Chi, B Dong, W Lv, L Shen… - International Journal of …, 2020 - Elsevier
Objectives Existing findings regarding the relationship between comorbidities and the
severity of coronavirus disease 2019 (COVID-19) are inconsistent and insufficient. The aim …
severity of coronavirus disease 2019 (COVID-19) are inconsistent and insufficient. The aim …
COVID‐19: immunopathology, pathophysiological mechanisms, and treatment options
LE van Eijk, M Binkhorst, AR Bourgonje… - The Journal of …, 2021 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), continues to spread globally despite the worldwide …
syndrome coronavirus 2 (SARS‐CoV‐2), continues to spread globally despite the worldwide …
Impact of comorbidities on patients with COVID‐19: a large retrospective study in Zhejiang, China
C Ye, S Zhang, X Zhang, H Cai, J Gu… - Journal of medical …, 2020 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) has become a serious public health
problem worldwide. Here, we stratified COVID‐19 patients based on their comorbidities to …
problem worldwide. Here, we stratified COVID‐19 patients based on their comorbidities to …
[HTML][HTML] Comorbidity and its impact on patients with COVID-19
A Sanyaolu, C Okorie, A Marinkovic, R Patidar… - SN comprehensive …, 2020 - Springer
A novel human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), was identified in Wuhan, China, in December 2019. Since then, the virus has made its …
2), was identified in Wuhan, China, in December 2019. Since then, the virus has made its …
相关搜索
- covid 19 meta analysis
- covid 19 clinical outcomes
- preexisting comorbidities clinical outcomes
- covid 19 preexisting comorbidities
- covid 19 immune pathophysiology
- covid 19 infected patients
- covid 19 cases duplication
- covid 19 deleterious impact
- covid 19 therapeutic interventions
- covid 19 mechanistic insights
- covid 19 comorbidities on patients
- covid 19 clinical symptoms
- covid 19 impact of comorbidities
- covid 19 pathophysiological mechanisms